EGF mutant receptor vIII as a molecular target in cancer therapy

Endocr Relat Cancer. 2001 Jun;8(2):83-96. doi: 10.1677/erc.0.0080083.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use
  • ErbB Receptors / genetics
  • ErbB Receptors / immunology*
  • Gene Expression Regulation, Neoplastic
  • Glioblastoma / immunology
  • Glioblastoma / therapy
  • Humans
  • Immunotherapy / methods*
  • Immunotoxins / immunology
  • Immunotoxins / therapeutic use
  • Mutation
  • Neoplasms / immunology*
  • Neoplasms / therapy*

Substances

  • Antibodies, Monoclonal
  • Immunotoxins
  • epidermal growth factor receptor VIII
  • ErbB Receptors